# Melior Pharmaceuticals I, Inc. — Form D

Melior Pharmaceuticals I, Inc. of EXTON, PA, a company, filed a Form D exempt-offering notice with the SEC on 2011-10-07. The offering totals $375K, of which $375K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-10-07
- Form: D
- Accession: 0001532246-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $375K
- Amount sold: $375K
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2011-09-26
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-166899

## Issuer

- Name: Melior Pharmaceuticals I, Inc.
- CIK: 0001532246
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 860 SPRINGDALE DRIVE, EXTON, PA, 19341
- Phone: 610-280-0633

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Robert Adelson | Director | Boston, MA |
| Perry Molinoff | Director | DALLAS, TX |
| Toby Moskovits | Director | Exton, PA |
| Andrew Reaume | Director | Exton, PA |
| Michael Saporito | Director | Exton, PA |
| Jeffrey Vaught | Director | Exton, PA |
| Bobba Venkatadri | Director | Exton, PA |
| Andrew Reaume | Executive Officer | Exton, PA |

## More

- [CIK 1532246 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1532246&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001532246-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.